Vincerx Pharma, Inc.
VINCDelisted Apr 28, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001796129
Vincerx Pharma, Inc. was delisted on Apr 28, 2025; its insiders filed their last Form 4 on Aug 14, 2024; 14 institutions reported holding it in 13F filings for Q1 2025, worth $116.8K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Vincerx Pharma, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +1 vs. Q2 2023
- Shares held
- 10.7M
- −1.37M (−11.3%) vs. Q2 2023
- Total value
- $10.8M
- −$4.87M (−31.0%) vs. Q2 2023
- New holders
- 5
- 6 more added
- Sold out
- 4
- 12 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VINC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 1 | $2 |
| Q1 2025 | 14 | $116.8K |
| Q4 2024 | 21 | $1.26M |
| Q3 2024 | 26 | $7.89M |
| Q2 2024 | 28 | $8.66M |
| Q1 2024 | 38 | $42.7M |
| Q4 2023 | 33 | $11.6M |
| Q3 2023 | 35 | $10.8M |
| Q2 2023 | 34 | $15.7M |
| Q1 2023 | 35 | $13.3M |
| Q4 2022 | 34 | $13.0M |
| Q3 2022 | 43 | $20.0M |
| Q2 2022 | 49 | $18.4M |
| Q1 2022 | 65 | $65.1M |
| Q4 2021 | 55 | $156.8M |
| Q3 2021 | 55 | $248.9M |
| Q2 2021 | 56 | $157.3M |
| Q1 2021 | 36 | $171.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Vincerx Pharma, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 2,062,926 | $2.08M | 0.00% | −240.0% | Reduced |
| Sage Rhino Capital LLC | 1,703,413 | $1.72M | 0.48% | +16,476+1.0% | Added |
| Bank of America Corp | 1,452,907 | $1.47M | 0.00% | +1,449,152+38,592.6% | Added |
| Long Focus Capital Management, LLC | 1,098,753 | $1.11M | 0.16% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 891,719 | $900.6K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 513,420 | $518.6K | 0.00% | −6,849−1.3% | Reduced |
| ExodusPoint Capital Management, LP | 389,512 | $393.0K | 0.01% | −36,960−8.7% | Reduced |
| Kingdon Capital Management, L.L.C. | 385,000 | $388.9K | 0.07% | 00.0% | Unchanged |
| Rubric Capital Management LP | 354,377 | $357.9K | 0.02% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 344,827 | $348.3K | 0.00% | −10.0% | Reduced |
| Tejara Capital Ltd | 233,348 | $235.7K | 0.13% | 00.0% | Unchanged |
| Citadel Advisors LLC | 168,829 | $173.9K | 0.00% | −491,693−74.4% | Reduced |
| Geode Capital Management, LLC | 154,031 | $158.7K | 0.00% | +17,153+12.5% | Added |
| Renaissance Technologies LLC | 132,900 | $134.0K | 0.00% | −26,200−16.5% | Reduced |
| Walleye Capital LLC | 115,044 | $118.5K | 0.00% | −20,000−14.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 114,000 | $115.1K | 0.00% | −487,645−81.1% | Reduced |
| Sio Capital Management, LLC | 102,049 | $103.1K | 0.03% | 00.0% | Unchanged |
| Clearline Capital LP | 98,916 | $99.9K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 64,259 | $64.9K | 0.00% | −1,676−2.5% | Reduced |
| Sabby Management, LLC | 57,353 | $57.9K | 0.18% | −45,747−44.4% | Reduced |
| State Street Corp | 43,143 | $44.4K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 41,830 | $42.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 40,000 | $42.0K | 0.00% | +40,000 | New |
| Millennium Management LLC | 37,054 | $38.2K | 0.00% | −21,982−37.2% | Reduced |
| Northern Trust Corp | 25,614 | $25.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 24,822 | $25.1K | 0.00% | +678+2.8% | Added |
| XTX Topco Ltd | 16,845 | $17.4K | 0.00% | +16,845 | New |
| Wade G W & Inc | 10,900 | $11.0K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 10,000 | $10.1K | 0.00% | −48,899−83.0% | Reduced |
| Tower Research Capital LLC (TRC) | 7,178 | $7.25K | 0.00% | +3,006+72.1% | Added |
| UBS Group AG | 5,736 | $5.79K | 0.00% | +5,736 | New |
| Barclays PLC | 2,556 | $2.58K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 126 | $127 | 0.00% | +2+1.6% | Added |
| FMR LLC | 6 | $6 | 0.00% | +6 | New |
| Qube Research & Technologies Ltd | 4 | $4 | 0.00% | +4 | New |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −1,492,771−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −225,579−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −10,446−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −394−100.0% | Sold out |